Evolent Health Inc. (EVH) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Evolent Health Inc. (EVH)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

11.26

-1.13 (-9.12%)

At close: Jan 14, 2025, 3:59 PM

11.22

-0.31%

Pre-market Jan 15, 2025, 04:01 AM EST

undefined% (undefined)

Bid	11.21
Market Cap	1.31B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-0.91
PE Ratio (ttm)	-12.37
Forward PE	n/a
Analyst	Buy

Ask	11.89
Volume	3,436,323
Avg. Volume (20D)	2,610,311
Open	12.70
Previous Close	12.39
Day's Range	11.13 - 12.70
52-Week Range	10.53 - 35.00
Beta	undefined

About EVH

Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management. It offers financial and adminis...

[Show more]

Industry Medical - Healthcare Information Services

Sector Healthcare

IPO Date Jun 5, 2015

Employees 4,700

Stock Exchange NYSE

Ticker Symbol EVH

Website https://www.evolenthealth.com

Analyst Forecast

According to 11 analyst ratings, the average rating for EVH stock is "Buy." The 12-month stock price forecast is $18, which is an increase of 59.93% from the latest price.

Buy 90.91%

Hold 9.09%

Sell 0.00%

Stock Forecasts

Next Earnings Release

Evolent Health Inc. is scheduled to release its earnings on Feb 20, 2025, during market hours.
Analysts project revenue of $652.46M, reflecting a 17.34% YoY growth and earnings per share of 0.05, making a -78.26% decrease YoY.

Why Price Moved

1 day ago · Source New

-9.77%

Evolent Health shares are trading lower after RBC ... Unlock content with Pro Subscription

2 months ago · Source

+13.25%

Evolent Health shares are trading higher. Barclays maintained an Overweight rating on the stock.

News

1 month ago · zacks.com

New Strong Sell Stocks for December 12th

ASH, BIDU and EVH have been added to the Zacks Rank #5 (Strong Sell) List on December 12, 2024.

2 months ago · seekingalpha.com

Evolent Health: A Shot At Revival After Market Bruising

Evolent Health has seen a significant 50% drop due to a Q3 earnings miss and high medical costs. Despite setbacks, Evolent secured record-breaking new business deals and anticipates over 15% annual re...

2 months ago · seekingalpha.com

Evolent Health, Inc. (EVH) Q3 2024 Earnings Call Transcript

Evolent Health, Inc. (NYSE:EVH ) Q3 2024 Earnings Conference Call November 7, 2024 5:00 PM ET Participants Seth Blackley - Chief Executive Officer John Johnson - Chief Financial Officer Seth Frank - V...

2 months ago · zacks.com

Compared to Estimates, Evolent Health (EVH) Q3 Earnings: A Look at Key Metrics

The headline numbers for Evolent Health (EVH) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Stree...

2 months ago · benzinga.com

Sweetgreen Posts Downbeat Results, Joins Evolent Health, Redfin, Pinterest And Other Big Stocks Moving Lower In Friday's Pre-Market Session

U.S. stock futures were slightly lower this morning, with the Nasdaq futures falling around 0.2% on Friday.

2 months ago · zacks.com

Evolent Health (EVH) Q3 Earnings and Revenues Lag Estimates

Evolent Health (EVH) came out with quarterly earnings of $0.04 per share, missing the Zacks Consensus Estimate of $0.30 per share. This compares to earnings of $0.30 per share a year ago.

2 months ago · zacks.com

Unlocking Q3 Potential of Evolent Health (EVH): Exploring Wall Street Estimates for Key Metrics

Beyond analysts' top -and-bottom-line estimates for Evolent Health (EVH), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the q...

2 months ago · zacks.com

Why Evolent Health (EVH) is Poised to Beat Earnings Estimates Again

Evolent Health (EVH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

2 months ago · zacks.com

Evolent Health (EVH) Reports Next Week: What to Know Ahead of the Release

Evolent Health (EVH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.